Diagnostics & Testing M&A Industry Update | May 2023

Share This Post

 

In this Diagnostics & Testing M&A Industry Update, we explore the M&A activity and projections for this sector within the Business Services industry. Within this report we provide key themes that are driving deal activity for Diagnostics & Testing companies, M&A activity updates, and up-to-date market data. The purpose of this report is to educate business owners and financial service providers on the trends and activity for May 2023, and projections for the future.

 

To read the full Diagnostics & Testing Industry Update, download below

 

If you are interested in discussing any of the analysis from this report, or if you would like to discuss your own transaction goals contact the Managing Directors from our Business Services Industry Group below, or reach out at (800) 849-7010 or [email protected] to be directed to the appropriate team member.

 

About the Authors:

Channing Hamlet headshotChanning Hamlet

Managing Director, Business Services Practice

310.570.2721

[email protected]

 


Disclosure

This news release is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.  Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities.

More Posts